PLN 10.0
(-1.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - PLN | 0.0% |
2022 | - PLN | 0.0% |
2021 | - PLN | 100.0% |
2020 | -3.68 Million PLN | 0.0% |
2019 | - PLN | -100.0% |
2018 | 94.38 Thousand PLN | -38.9% |
2017 | 154.48 Thousand PLN | 15448200.0% |
2016 | 1.00 PLN | 100.0% |
2015 | -1.25 Million PLN | 0.0% |
2014 | - PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - PLN | 0.0% |
2024 Q2 | 1.55 Million PLN | 0.0% |
2024 Q3 | -510.26 Thousand PLN | -100.0% |
2023 Q2 | 1.29 Million PLN | 1.81% |
2023 Q3 | 1.46 Million PLN | 12.97% |
2023 Q4 | - PLN | -100.0% |
2023 FY | - PLN | 0.0% |
2023 Q1 | 1.27 Million PLN | 0.0% |
2022 Q3 | - PLN | -100.0% |
2022 Q2 | 1.00 PLN | 0.0% |
2022 FY | - PLN | 0.0% |
2022 Q1 | 1.00 PLN | 0.0% |
2022 Q4 | - PLN | 0.0% |
2021 Q4 | - PLN | -100.0% |
2021 Q3 | 1.00 PLN | 200.0% |
2021 Q2 | -1.00 PLN | 0.0% |
2021 FY | - PLN | 100.0% |
2021 Q1 | - PLN | 0.0% |
2020 Q1 | - PLN | 100.0% |
2020 Q2 | - PLN | 0.0% |
2020 FY | -3.68 Million PLN | 0.0% |
2020 Q4 | - PLN | -100.0% |
2020 Q3 | 1.00 PLN | 0.0% |
2019 Q4 | -1931.00 PLN | -193200.0% |
2019 FY | - PLN | -100.0% |
2019 Q3 | 1.00 PLN | 0.0% |
2019 Q2 | 1.00 PLN | 0.0% |
2019 Q1 | 1.00 PLN | -100.0% |
2018 Q4 | 713.54 Thousand PLN | 71354200.0% |
2018 FY | 94.38 Thousand PLN | -38.9% |
2018 Q1 | 1.09 Million PLN | 20.1% |
2018 Q2 | 1.02 Million PLN | -6.76% |
2018 Q3 | 1.00 PLN | -100.0% |
2017 Q2 | 1.00 PLN | 0.0% |
2017 FY | 154.48 Thousand PLN | 15448200.0% |
2017 Q3 | 1.00 PLN | 0.0% |
2017 Q4 | 913.84 Thousand PLN | 91384500.0% |
2017 Q1 | - PLN | -100.0% |
2016 Q4 | 1.00 PLN | 0.0% |
2016 FY | 1.00 PLN | 100.0% |
2016 Q1 | - PLN | 0.0% |
2015 FY | -1.25 Million PLN | 0.0% |
2014 FY | - PLN | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bioceltix S.A. | 8617.89 PLN | 100.0% |
BIOTON S.A. | 117.91 Million PLN | 100.0% |
Captor Therapeutics Spolka Akcyjna | - PLN | NaN% |
Mabion S.A. | 6.84 Million PLN | 100.0% |
NanoGroup S.A. | 63.37 Thousand PLN | 100.0% |
Pharmena S.A. | 445 Thousand PLN | 100.0% |
Poltreg S.A. | 415 Thousand PLN | 100.0% |
Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 100.0% |
Ryvu Therapeutics S.A. | 2.11 Million PLN | 100.0% |
Synthaverse S.A. | 15.48 Million PLN | 100.0% |
Urteste S.A. | 162 Thousand PLN | 100.0% |